- Home
- HONE vs XNCR Comparison
HONE vs XNCR Comparison
Compare HONE & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HONE
- XNCR
- Stock Information
- Founded
- HONE 1917
- XNCR 1997
- Country
- HONE United States
- XNCR United States
- Employees
- HONE N/A
- XNCR N/A
- Industry
- HONE Major Banks
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- HONE Finance
- XNCR Health Care
- Exchange
- HONE Nasdaq
- XNCR Nasdaq
- Market Cap
- HONE 513.0M
- XNCR 547.8M
- IPO Year
- HONE 2016
- XNCR 2013
- Fundamental
- Price
- HONE $12.69
- XNCR $8.41
- Analyst Decision
- HONE Buy
- XNCR Buy
- Analyst Count
- HONE 3
- XNCR 9
- Target Price
- HONE $14.50
- XNCR $25.00
- AVG Volume (30 Days)
- HONE 183.7K
- XNCR 718.6K
- Earning Date
- HONE 07-24-2025
- XNCR 08-06-2025
- Dividend Yield
- HONE 2.98%
- XNCR N/A
- EPS Growth
- HONE 71.76
- XNCR N/A
- EPS
- HONE 0.65
- XNCR N/A
- Revenue
- HONE $164,819,000.00
- XNCR $146,929,000.00
- Revenue This Year
- HONE N/A
- XNCR N/A
- Revenue Next Year
- HONE $9.44
- XNCR $28.84
- P/E Ratio
- HONE $18.62
- XNCR N/A
- Revenue Growth
- HONE N/A
- XNCR N/A
- 52 Week Low
- HONE $8.89
- XNCR $6.92
- 52 Week High
- HONE $13.73
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- HONE 67.29
- XNCR 55.89
- Support Level
- HONE $11.87
- XNCR $7.13
- Resistance Level
- HONE $12.29
- XNCR $7.99
- Average True Range (ATR)
- HONE 0.23
- XNCR 0.53
- MACD
- HONE 0.05
- XNCR 0.06
- Stochastic Oscillator
- HONE 100.00
- XNCR 94.90
About HONE HarborOne Bancorp Inc.
HarborOne Bancorp Inc is a bank holding company. The company is engaged in providing financial services like accepting deposits, lending loans, online and mobile banking, cash management, credit cards, money market accounts, and wealth management. The Company has two reportable segments: HarborOne Bank and HarborOne Mortgage. The bank provides financial services to individuals and businesses online and through its full-service branches located in Massachusetts and Rhode Island, one limited-service branch, and a commercial lending office in Boston, Massachusetts, and Providence, Rhode Island.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.